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HPV Type 16 Infection Switches Keratinocytes
from Apoptotic to Proliferative Fate under
TWEAK/Fn14 Interaction
Hong Cheng1,2,8, Na Zhan3,8, Dong Ding4, Xiaoming Liu5, Xiaoyan Zou6, Ke Li7 and Yumin Xia1
Previously, tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) had been known to be an
inducer of apoptosis of keratinocytes by engaging the Fn14 receptor. However, the high-risk human
papillomavirus (HPV) infection confers a proliferation advantage on keratinocytes that may consequently harbor
tumorigenicity. This study was designed to investigate the cross-talk in keratinocytes between TWEAK/Fn14
signaling and HPV type 16 infection, which may cooperate in regulating cell-cycle progression. TWEAK and Fn14
expression was determined in anogenital warts and normal skin. Both primary keratinocytes and HaCaT cells
were transfected with HPV16 E6/E7 genes. The results showed that Fn14 is highly expressed upon HPV16
transfection and accompanied by an increase in Ras GTPase activity and TNF-receptor-associated factor 2 (TRAF2)
expression. Moreover, the E6/E7-transfected keratinocytes exhibit a shift of TNF receptor proﬁle from type 1 to
type 2 and weakened apoptotic response to TNF-α stimuli, when compared with the normal control. Surprisingly,
signiﬁcant increase in proliferation but not apoptosis was seen in E6/E7-positive keratinocytes, as TWEAK was
additionally supplemented. In conclusion, the HPV16 infection in keratinocytes causes a switch of apoptotic to
proliferative fate under TWEAK/Fn14 interaction, possibly by favoring Ras and TRAF2 activation and modulating
TNF receptor expression.
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INTRODUCTION
As a novel member of the tumor necrosis factor (TNF)-ligand
superfamily, TNF-like weak inducer of apoptosis (TWEAK)
promotes the expression of proinﬂammatory mediators from
various cell types, including endothelial cells, epithelial cells,
and keratinocytes (Jin et al., 2004; Chen et al., 2011a; Xia et al.,
2015). Fibroblast growth factor inducible 14 (Fn14) is a sole
known receptor for TWEAK and induces the phosphorylation
of IκB kinase in keratinocytes when bound to TWEAK,
followed by augmented production of RANTES (regulated on
activation normal T cell expressed and secreted; Jin et al.,
2004). The role of the TWEAK/Fn14 pathway in skin diseases
has attracted increasing attention in recent years. High
expression of Fn14 has been found in the skin lesion of
atopic dermatitis and psoriasis (Zimmermann et al., 2011),
seborrheic eczema (Chen et al., 2011b), and cutaneous lupus
erythematosus (Doerner et al., 2015). Moreover, the TWEAK/
Fn14 interaction was proven to induce keratinocyte apoptosis
by cooperating with TNF-α (Zimmermann et al., 2011) and
through the translocation of apoptosis-inducing factor to the
nucleus that affects G2/M growth arrest (Sabour Alaoui et al.,
2012). However, the role of the TWEAK/Fn14 pathway in
regulating the cell fate of human papillomavirus (HPV)-infected
keratinocytes has not been explored up to date, which is
characterized by increased proliferation but not apoptosis.
HPV-infected keratinocytes in anogenital lesions are sub-
ject to particularly intense investigation as a result of a strong
etiological association with carcinogenesis (Chelimo et al.,
2013). In recent years, more strong evidence is provided that
the E6 and E7 oncogenes of the high-risk HPV type 16
contribute to the immortalization of keratinocytes. The E6/E7
oncoproteins regulate the apoptosis-related retinoblastoma
protein (pRB) and p53 pathways (Zheng and Wang, 2011),
cause genomic instability that favors additional mutations
(Chen, 2010), reactivate the DNA synthesis progression of cell
cycle (Chow et al., 2009), and alter the expression of
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angiogenic factors (Chen et al., 2007). Until now, the HPV16-
induced keratinocyte immortalization has been suggested to
correlate closely with epidermis-originated malignancies,
such as cervical cancer, Bowen's disease, and cutaneous
and oropharyngeal squamous-cell carcinoma (Mii et al.,
2011; Gillison et al., 2012; Aldabagh et al., 2013; Chelimo
et al., 2013).
Interestingly, elevated expression of Fn14 has also been
found in the keratinocyte-originated cancers (cervical carci-
noma, esophageal cancer; Yoriki et al., 2011; Zou et al.,
2011) or immortal cancer cell lines (Culp et al., 2010; Ikner
and Ashkenazi, 2011; Zhou et al., 2011), which enables Fn14
as a promising target in the treatment of cancers. The
dysfunctional TWEAK/Fn14 interaction is involved in the
proliferation, survival, invasion, and angiogenesis of tumors
(Michaelson and Burkly, 2009). Thus, these prior ﬁndings
indicated the possibility that HPV infection may be connected
to the TWEAK/Fn14-mediated cell fate. Indeed, the
elucidation of molecular mechanism that the TWEAK/Fn14
pathway modulates the biological behavior of tumor cells
helps in developing novel therapies taking advantage of Fn14
overexpression. Therefore, this study was designed to explore
the HPV-dependent status and TWEAK/Fn14 function in
human keratinocytes.
RESULTS
Increased TWEAK and Fn14 expression accompanies HPV type
16 infection
We determined the TWEAK levels in human tissues or sera
and the Fn14 expression by keratinocytes. By immunohis-
tochemistry, stronger TWEAK expression was veriﬁed in the
HPV16-positive warts, especially the dermo–epidermal junc-
tion areas, when compared with normal skin (Figure 1a).
Statistical variance was further found in the TWEAK level of
tissue lysates, whereas the sera analysis revealed no
difference between the patients with warts and healthy
donors (Figure 1b). Moreover, higher Fn14 expression was
observed in warts, when compared with slight Fn14 staining
in normal epidermis (Figure 1c). Consistently, higher mRNA
level was seen with wart samples (Figure 1d). For the
keratinocytes isolated from skin, both immunoﬂuorescence
(Figure 1e) and western blotting (Figure 1f) conﬁrmed such
Fn14 overexpression in warts, which was quantitatively
ascertained by ﬂow cytometry (Figure 1g and h). A similarity
of Fn14 expression was seen in foreskin-derived primary
keratinocytes (Supplementary Figure S1 online) and immortal
HaCaT cells (Supplementary Figure S2 online), whereas they
were transfected with HPV16 E6/E7 genes. Interestingly, the
constaining of Fn14 and HPV16 E6 was performed with
wart-derived keratinocytes, showing signiﬁcant overlap of
Fn14 and E6 expression (Supplementary Figure S1 online).
Furthermore, these HPV-infected tissues were evaluated for
inﬂammatory response that may be related to the TWEAK/
Fn14 activation, revealing higher expression of RANTES,
TNF-α, and NF-κB and stronger inﬁltration of Iba-1-positive
cells when compared with the controls (Supplementary Figure
S3 online).
TWEAK/Fn14 interaction enhances proliferation of HPV16-
positive keratinocytes
The effect of TWEAK/Fn14 interaction on cell proliferation
and apoptosis was studied with fresh tissues or HPV16 E6/E7-
transfected HaCaT cells. Ki-67 staining showed more positive
cells in the epidermis from warts than normal controls,
although there was no difference in apoptotic cells between
them, leading to a signiﬁcant difference in the proliferation to
apoptosis ratio (Supplementary Figure S4 online). Moreover,
the wart-derived keratinocytes were cultured in vitro and
under the stimulation of exogenous TWEAK, which induced
higher proliferation to apoptosis ratio (Figure 2a–c).
The dose dependence was analyzed with primary kerati-
nocytes derived from foreskin, showing that HPV16
E6/E7-transfected cells proliferated increasingly with TWEAK
at a range of 0–2,000 ngml−1 (Figure 2d). However, the
untransfected cells responded differentially to TWEAK stimu-
lation, displaying a dose-dependent increase in apoptosis
(Figure 2e). These E6/E7-positive keratinocytes were further
transfected with Fn14 siRNA, showing that the cell prolifera-
tion upon TWEAK stimulation was inhibited completely
(Figure 2f). In addition, TWEAK enhanced the levels of
RANTES, monocyte chemotactic protein-1, and IFN-γ–
induced protein 10 in E6/E7-positive cells (Figure 2g). Similar
results were seen with the E6/E7-transfected HaCaT cells
(Supplementary Figure S2 online).
Both Ras GTPase activity and TRAF2 expression increase with
E6/E7 transfection
The Ras GTPase activity was determined in foreskin-derived
primary keratinocytes. E6/E7 transfection caused an increase
in Ras GTPase activity when compared with the untransfected
keratinocytes (Figure 3a). Moreover, the inhibition of the Ras
pathway by farnesylthiosalicylic acid partially abrogated the
promotion effect of TWEAK on the proliferation of E6/E7-
transfected cells (Figure 3b). Similarly, the expression of TNF-
receptor–associated factor 2 (TRAF2) was evaluated in these
keratinocytes, showing higher mRNA and protein levels upon
E6/E7 transfection (Figure 3c and d). Furthermore, a secondary
transfection with TRAF2 siRNA was performed in the E6/E7-
transfected keratinocytes, leading to a reduction in TWEAK-
facilitated proliferation (Figure 3e).
HPV16 E6/E7-transfected keratinocytes synthesize TNF-R2
predominantly
TWEAK has been proven to cooperate with TNF-α in
modulating the cell-cycle progression of keratinocytes
(Zimmermann et al., 2011). Regarding the high level of
TNF-α in wart tissues, we determined the possible changes of
TNF receptor (TNF-R) expression upon HPV16 infection. Flow
cytometry results displayed a signiﬁcant decrease in TNF-R1
expression by HaCaT cells after HPV16 E6/E7 transfection,
which was even enhanced by TWEAK, whereas the reverse
effect of E6/E7 transfection and TWEAK stimulation was seen
with TNF-R2 expression (Figure 4a and b). By confocal
analysis, HaCaT cells exhibited the weakest expression of
TNF-R1 but the strongest of TNF-R2, respectively, upon E6/E7
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plus TWEAK treatment (Figure 4c), which was further
conﬁrmed by mRNA analysis (Figure 4d).
Apoptotic response to TNF-α stimuli is largely silenced in
HPV16 E6/E7-transfected keratinocytes
As the TNF-R expression proﬁle alters with HPV16 E6/E7
transfection, we investigated the fate of E6/E7-positive
HaCaT cells that were stimulated by TNF-α alone or plus
TWEAK. The results showed that the percentage of apoptotic
cells increased dose dependently as TNF-α was added to
normal HaCaT cells (Figure 5a). However, these cells did not
obey such a rule once transfected with HPV16 E6/E7 genes.
The addition of TWEAK caused relatively more plateaued
curve responding to TNF-α stimuli, although not differing from
the E6/E7+/TWEAK− group. Moreover, the E6/E7-transfected
cells exhibited an increase in proliferation upon the TNF-α
plus TWEAK stimulation, whereas a decrease was seen in
non-TWEAK-treated cells (Figure 5b).
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Figure 1. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and ﬁbroblast growth factor-inducible 14 (Fn14) expression is increased in
wart tissues and keratinocytes. (a) Immunohistochemistry was performed for TWEAK expression in the parafﬁn sections. (b) TWEAK was quantitatively measured
in both tissue lysates and sera. (c) By immunohistochemistry, Fn14 was detected in the parafﬁn sections. (d) Fn14 mRNA was determined in total RNA extracted
from fresh tissues. By immunoﬂuorescence (e), western blotting (f), and ﬂow cytometry (g and h), Fn14 expression was evaluated in the primary keratinocytes
isolated from fresh tissues. Number of wart samples=11, of normal skin=5. Representative images are shown. Bars=50 μm. *Po0.05. PE, phycoerythrin.
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The protein expression of pRB and p130 exhibited similar
results that TNF-α stimulation induced degradation (from
hyper- or phosphorylated to hypo- or unphosphorylated
forms) in untransfected HaCaT cells, which was not seen in
E6/E7-transfected cells regardless of adding TWEAK
(Figure 5c). The combination of E6/E7 transfection and
TWEAK stimulation augmented the synthesis of cyclin A
and proliferating cell nuclear antigen. The mRNA analysis
revealed no effect of E6/E7 transfection alone or in combina-
tion with TWEAK stimulation on the pRB and p130 expression
Figure 2. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) promotes proliferation and cytokine production of keratinocytes.
(a) Fluorescent detection and the TUNEL assay were performed on primary keratinocytes from tissues. Both proliferation (b) and apoptosis (c) levels were
quantitated and then normalized to the nontreated normal groups accordingly. TWEAK affected proliferation to apoptosis ratio in a dose-dependent manner,
which was positive in E6/E7-transfected cells (d) but negative in untransfected cells (e). (f) E6/E7-positive cells were evaluated for the effect of ﬁbroblast growth
factor-inducible 14 (Fn14) siRNA transfection on the TWEAK promotion of proliferation. (g) Proinﬂammatory cytokines were determined in E6/E7-positive cells
after TWEAK stimulation. In a–c, number of wart samples=11, of normal skin=5. In d–g, primary cells were from foreskin epidermis (n=3). For a, b, c, f, g,
TWEAK was at 0.5 μgml−1 in media for 2 days. Bars = 20 μm; *Po 0.05. IP-10, interferon gamma-induced protein 10; MCP-1, monocyte chemotactic protein-1;
RANTES, regulated on activation normal T-cell expressed and secreted.
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Figure 3. The assessment of Ras GTPase activity and tumor necrosis factor (TNF)-receptor–associated factor 2 (TRAF2) expression in foreskin-derived primary
keratinocytes. (a) Ras GTPase activity was measured in cells treated by E6/E7 transfection or TNF-like weak inducer of apoptosis (TWEAK). (b) Keratinocytes were
evaluated for the effect of farnesylthiosalicylic acid (10 μM) on the TWEAK promotion of proliferation. (c and d) The mRNA (c) and protein (d) levels of TRAF2 were
determined in the keratinocytes transfected with E6/E7 genes. (e) The effect of TRAF2 siRNA transfection on proliferation was assessed in the cells with or without
TWEAK stimulation. Data were from three independent experiments, and representative image was shown. *Po0.05.
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(Figure 5d), excluding the possible mechanism of pRB or p130
gene regulation in the silencing of cell apoptosis due to TNF-α
stimuli.
The activation of cytoplasmic caspase-8 propagates various
apoptotic signals in keratinocytes (Lotti et al., 2010). The
analysis of cytoplasmic proteins showed that, although the
procaspase-8 (p55/54) and intermediate cleavage products
(p43/41) displayed no difference, the p18 active subunit
decreased signiﬁcantly in E6/E7-positive HaCaT cells upon
TWEAK stimulation. The CaspaTag activity detection pro-
vided more evidence that the E6/E7 plus TWEAK treatment
inhibited cytoplasmic expression of caspase-8 by
HaCaT cells. See Supplementary Figure S5 online.
DISCUSSION
In this study, we demonstrated that both HPV16-positive warts
and HPV16 E6/E7-harboring keratinocytes express high levels
of Fn14, which interacts with TWEAK causing proliferation of
keratinocytes. The E6/E7 oncoproteins inhibit the caspase-8
synthesis, promote Ras GTPase activity and TRAF2 expression,
elicit a TNF-R2 prevailing proﬁle, and then confer cell
apoptotic resistance to TNF-α. The properties-altered kerati-
nocytes respond to TWEAK/Fn14 activation with augmented
proliferation but not apoptosis, the latter of which has been
observed in non-HPV-infected keratinocytes or skin tissues
(Chen et al., 2011b; Peternel et al., 2011; Zimmermann et al.,
2011; Sabour Alaoui et al., 2012). In this study, we discovered
the highly activated TWEAK/Fn14 pathway in HPV infection
and the reversion of HPV16 E6/E7 oncoproteins on the
keratinocyte fate elicited by such an activation.
Besides high-level Fn14 in HPV16-positive or E6/E7-
transfected keratinocytes, TWEAK expression is also elevated
in wart lesions. However, the serum TWEAK is stable in the
patients with anogenital warts. Such a discrepancy in TWEAK
expression may be explained by the largely local but not
systemic inﬂammation caused by HPV infection (Stanley,
2006). Actually, the increase in TWEAK in wart regions
coincides with the augmented inﬁltration of macrophages (Iba-
1 positive) that are considered as major TWEAK-secreting cells
(Girgenrath et al., 2006). Moreover, the downstream proteins,
RANTES and NF-κB, are expressed increasingly in warts,
indicating a TWEAK/Fn14 activation. The E6/E7-transfected
cells even produce more RANTES, monocyte chemotactic
protein-1, and IFN-γ–induced protein 10 upon TWEAK
stimulation. These ﬁndings not only verify the previous
reports that TWEAK/Fn14 interaction in keratinocytes
induces the synthesis of proinﬂammatory factors, which is
accompanied by activating NF-κB signals (Jin et al., 2004;
Zimmermann et al., 2011; Sabour Alaoui et al., 2012), but also
conﬁrm the TWEAK/Fn14 activation in HPV16-infected cells.
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It was demonstrated that TWEAK expression increases in most
malignancies when compared with the normal tissues
(Winkles et al., 2007; Wajant, 2013). However, TWEAK was
also found lower in cervical carcinoma and intraepithelial
neoplasms (Zou et al., 2011), which have been implied to
associate with HPV infection (Chelimo et al., 2013). The tumor
microenvironment contains some factors implicated in
upregulating TWEAK expression, including the inﬁltration of
immune cells that represent a bona ﬁde source of TWEAK
(Wajant, 2013). The discrepancy in TWEAK expression
between HPV-positive warts and cervical carcinoma/neo-
plasms could not exclude the effect of biopsy sites or tumor
grades and deserves further study.
TWEAK induces apoptosis through a death-signaling com-
plex comprising receptor-interacting protein 1, Fas-associated
death domain, and caspase-8 (Wang et al., 2010a; Ikner and
Ashkenazi, 2011). Our results show signiﬁcant reduction in
cytoplasmic p18 (active subunit) upon E6/E7 transfection,
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which was even augmented by TWEAK, suggesting the
caspase-8 inhibition involved in TWEAK-induced keratinocyte
proliferation. Actually, the E6 protein prevents apoptosis of
infected cells through binding to caspase-8 (Yuan et al., 2012)
and also recruits active caspase-8 from the cytoplasm to the
nuclei (Manzo-Merino et al., 2014). Hence, the TWEAK/Fn14
mediates the proliferation of E6/E7-positive cells by inhibiting
the caspase-8 pathway.
TWEAK promotes the proliferation of renal ﬁbroblast
through activation of the Ras/ERK pathway (Ucero et al.,
2013), and the Ras GTPase activity reﬂects the activation of
the Ras pathway (Muro et al., 2015). Consistently, our results
prove the elevation of Ras GTPase activity in primary
keratinocytes upon HPV E6/E7 transfection and the partial
abrogation of TWEAK-promoted cell proliferation by speciﬁc
Ras inhibitor. Actually, the activation of the Ras pathway
participates in the cell transformation induced by HPV16
oncogenes (Gu and Matlashewski, 1995) and cooperates with
E7 protein in modifying the proliferation and invasiveness
properties of keratinocytes (Yoshida et al., 2008). Moreover,
the overexpression of active form of Ras promotes synthesis of
HPV-16 E6/E7 RNAs and mediates growth stimulation of
immortal keratinocytes by TNF-α (Gaiotti et al., 2000).
Therefore, our ﬁndings support the assumption that HPV
infection favors TWEAK-induced keratinocyte proliferation by
facilitating Ras activation.
TRAF2 is an anti-apoptotic protein and functions in the
TWEAK/Fn14 activation by binding to the intracellular part of
Fn14 (Wicovsky et al., 2009). In this study, TRAF2 expression
was enhanced in keratinocytes after E6/E7 transfection. Hence,
the elevated TRAF2 level may also be responsible for the
TWEAK-induced keratinocyte proliferation. It was reported
that cIAP1-TRAF2 complex overexpression protects tumor
cells from TWEAK-induced TNF-α sensitization that kills tumor
cells (Vince et al., 2008). Moreover, the EVER2 deﬁciency in
keratinocytes can create an environment conducive to HPV
replication and also impair TRAF production and sustain
TRAF2 ubiquitination (Vuillier et al., 2013). TRAF2 is crucial in
the downstream regulation of gene expression triggered by
TWEAK/Fn14 interaction (Vucic, 2013). Our ﬁndings not only
demonstrated the effect of HPV E6/E7 on TRAF2 expression
but also revealed different mechanisms underlying the HPV
modulation of TWEAK/Fn14 function.
TNF-α regulates cell cycle by binding to either of the two
receptors. The interaction with TNF-R1 leads to caspase-8
activation and induces apoptosis ultimately. However, TNF-
R2 antagonizes TNF-R1-induced caspase signaling and
enhances cell proliferation by triggering the NF-κB pathway
(Faustman and Davis, 2010). Both TNF-R1 and TNF-R2 may
express in epidermis keratinocytes but with biased differ-
ences, which generate cell fate diversity (Arnott et al., 2004;
Kerstan et al., 2011). Our results show high TNF-α expression
in HPV-positive lesions as reported previously (Wang et al.,
2010b). Under certain inﬂammation, TWEAK and TNF-α
cooperate in the induction of keratinocyte apoptosis
(Zimmermann et al., 2011). However, this study revealed a
reverse effect of TWEAK on cell fate. The apparently altered
proﬁle of TNF-α receptors in HPV-infected keratinocytes may
explain such a fate switch. Actually, TWEAK inhibits TNF-R1
signaling through desensitizing cells in response to TNF
stimuli (Wicovsky et al., 2009). The competitive inhibition of
TNF-R1 activation enlarges the effect of TNF-R2 activation,
which favors cell proliferation. Hence, the predominant TNF-
R2 expression in HPV-infected keratinocytes facilitates the
effect of TWEAK/Fn14 activation in enhancing cell
proliferation.
In conclusion, the high expression of TWEAK and Fn14
accompanies HPV type 16 infection, and TWEAK/Fn14
activation induces the proliferation but not apoptosis of
keratinocytes upon the expression of E7/E7 oncoproteins. This
signiﬁcant change of cell fate may be due to the HPV
infection–promoted Ras and TRAF2 activation and the
alteration of TNF-α receptor proﬁle, the latter of which leads
to a silenced apoptotic response to TNF-α stimuli. Future
studies should be focused on the HPV16 E6/E7-induced
changes of keratinocyte gene expression proﬁle that may be
related to TWEAK/Fn14-mediated cell-cycle regulation.
MATERIALS AND METHODS
Tissue collection
As described previously (Williams et al., 1994), the anogenital wart
biopsies (n=11) were obtained from the outpatient donors. HPV16
infection was veriﬁed by PCR. Each biopsy was divided into two parts,
one processed for parafﬁn sections and the other cultured in DMEM.
The site-matched normal skin (n=5) was obtained from the donors
with cosmetic or trauma surgery. For the isolation of primary
keratinocytes, the fresh epidermis was obtained from neonatal foreskin.
Sera were collected from tissue donors. The protocols were approved
by the Research Ethics Committee of the hospitals. Written informed
patient consent was obtained before collecting tissue samples.
Immunohistochemistry
Parafﬁn sections were routinely processed before blocking with Dual
Endogenous Enzyme Block (DAKO, Glostrup, Denmark). Rabbit anti-
Fn14 IgG (4 μgml−1; Cell signaling, Danvers, MA) was applied to
sections for 30minutes at room temperature. Following wash, the
sections were incubated with polymer-horseradish peroxidase-
conjugated goat anti-rabbit IgG and then 3,3′-diaminobenzine-
chromogen (DAKO). Similarly, sections were also stained for TWEAK
(Thermo Fisher Scientiﬁc, Waltham, MA), Ki-67 (Accurate Chemical,
Westbury, NY), RANTES (AbD Serotec, Raleigh, NC), or Iba-1
(Abcam, Cambridge, MA).
Cell culture and retroviral infection
After the removal of subcutaneous fat and reticular dermis, fresh
tissues were cut into small strips, followed by 0.5% trypsin
incubation. Tissues were disaggregated with Pasteur pipette to obtain
a single-cell suspension. The isolated keratinocytes were seeded into
DMEM-ﬁlled ﬂask with 10% fetal bovine serum. The passage 0 to 2
cells that had positive HPV DNA were used for the next experiments
(Williams et al., 1994). The keratinocytes from controls were
processed similarly. The primary keratinocytes from foreskin
epidermis were isolated as described previously (Rohani et al.,
2014). The culture media were refreshed everyday to minimize the
residual cytokines from biopsies, showing no detectable epidermal
growth factor and keratinocyte growth factor (not shown).
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Retroviral infection was performed as described previously (Zou
et al., 2015). Brieﬂy, the high-titer retroviral supernatants were
generated to infect cells under logarithmic growth phase. After
infection using pBabe vector (Cell Biolabs, San Diego, CA) inserted
with E6/E7 genes, keratinocytes were selected in G418 solution. The
E6/E7 genes were PCR veriﬁed in total RNA extractions, as the E6/E7
proteins were detected by an ELISA kit (OncoHealth, San Jose, CA).
The transfection of TRAF2 siRNA (Santa Cruz Biotechnology, Dallas,
TX) was performed in the E6/E7-positive keratinocytes (Li et al., 2012),
and an efﬁciency of 480% was conﬁrmed by quantitative real-
time PCR.
Keratinocytes were starved routinely before the 2-day stimulation
of recombinant human TWEAK (Cell Sciences, Canton, MA),
farnesylthiosalicylic acid (Sigma-Aldrich, St Louis, MO), or TNF-α
(10 ng/ml; Southern Biotech, Birmingham, AL). Supernatants and
cells were harvested for the next experiments.
ELISAs
Some tissue strips from above were smashed for lysates
(Zimmermann et al., 2011). TWEAK in human sera and tissue
lysates was determined with an ELISA Kit (Assay Biotech, San
Francisco, CA). TNF-α in tissue lysates was analyzed by ELISA
(Thermo Fisher Scientiﬁc). RANTES, monocyte chemotactic protein-
1, and IFN-γ–induced protein 10 (R&D Systems, Minneapolis, MN)
were determined in culture supernatants. The ELISA assay of Ras
GTPase activity (Active Motif, La Hulpe, Belgium) was performed as
described previously (Ucero et al., 2013), and Ras GTP activation
was expressed in n-fold versus control.
Proliferation and apoptosis assays
The skin specimens were examined for cell proliferation by detecting
Ki-67-positive cell (Xie et al., 2012). The apoptotic cells were
visualized by the TUNEL method (Greene et al., 2013). The
Proliferation (apoptosis) index was equal to the number of Ki-67-
positive cells (apoptotic bodies) assessed per 100 random nuclei. The
proliferation to apoptosis ratio was calculated by dividing Ki-67
labeling index with apoptosis index.
The cultured cells were visualized by Ki-67 staining and TUNEL as
above. Besides, cells were quantitatively measured for apoptosis by a
CaspaTagCaspase 3,7 kit (EMD Millipore, Billerica, MA) and for
proliferation by CellTiter 96 Solution (Promega, Madison, WI),
respectively.
Flow cytometry and immunoﬂuorescent detection
The pycoerythrin-conjugated anti-Fn14 or anti-TNF-R1 (or R2; Santa
Cruz Biotechnology) was used in ﬂow cytometry (BD Biosciences,
San Jose, CA). Data were analyzed using FlowJo7.6.1 software (Tree
Star, Ashland, OR). Keratinocytes growing on cover glasses were
stained with ﬂuorescein isothiocyanate-labeled antibodies targeting
Fn14 or TNF-R1/R2 (Santa Cruz Biotechnology) or Alexa Fluor 647-
conjugated IgG targeting HPV16 E6 (Gentaur, Kampenhout, Belgium)
before immunoﬂuorescence or confocal microscopy (Leica, Wetzlar,
Germany). At the single-cell level, cytoplasmic caspase-8 activity
was detected with a CaspaTagcaspase-8 kit (EMD Millipore).
Quantitative real-time PCR
Total RNA was extracted from fresh tissues or cultures by the
PureLink RNA kit (Invitrogen, Grand Island, NY). Reverse
transcription was performed using a cDNA kit (Applied Biosystems,
Carlsbad, CA). Quantitative real-time PCR was carried out on
7,900HT Fast PCR System (Applied Biosystems; Xia et al., 2012).
The primers are detailed in Supplementary Table S1 online.
Western blotting
Protein lysates were extracted from fresh tissues or cultures. For
caspase-8 detection, cytoplasmic proteins were extracted using NE-
PER reagent (Thermo Fisher Scientiﬁc). All samples were separated by
electrophoresis before transferring onto polyvinylidene diﬂuoride
membranes, which were then incubated with primary antibodies and
biotinylated secondary antibodies (Santa Cruz Biotechnology) in order.
Horseradish peroxidase–streptavidin was added before ECL signal
detection (Thermo Fisher Scientiﬁc). The intensities of bands were
measured by ImageJ and normalized to β-actin bands accordingly.
Statistical analysis
Statistical analysis was performed using the STATA 10.0 software
package (StataCorp, College Station, TX). All data are expressed as
the means± SEM. Spearman’s rank correlation coefﬁcients were used
for analyzing dose-dependent relationships. The signiﬁcance in
differences was tested using unpaired Student's t-tests. Differences
were considered signiﬁcant at Po0.05.
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